288 related articles for article (PubMed ID: 28797057)
1. Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways.
Farizatto KLG; Ikonne US; Almeida MF; Ferrari MFR; Bahr BA
PLoS One; 2017; 12(8):e0182895. PubMed ID: 28797057
[TBL] [Abstract][Full Text] [Related]
2. The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.
Hwang J; Estick CM; Ikonne US; Butler D; Pait MC; Elliott LH; Ruiz S; Smith K; Rentschler KM; Mundell C; Almeida MF; Stumbling Bear N; Locklear JP; Abumohsen Y; Ivey CM; Farizatto KLG; Bahr BA
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505809
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models.
Butler D; Hwang J; Estick C; Nishiyama A; Kumar SS; Baveghems C; Young-Oxendine HB; Wisniewski ML; Charalambides A; Bahr BA
PLoS One; 2011; 6(6):e20501. PubMed ID: 21695208
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis--an approach for slowing Alzheimer disease?
Bendiske J; Bahr BA
J Neuropathol Exp Neurol; 2003 May; 62(5):451-63. PubMed ID: 12769185
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.
Wang C; Sun B; Zhou Y; Grubb A; Gan L
J Biol Chem; 2012 Nov; 287(47):39834-41. PubMed ID: 23024364
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition increases tau accumulation independent of phosphorylation.
Liu YH; Wei W; Yin J; Liu GP; Wang Q; Cao FY; Wang JZ
Neurobiol Aging; 2009 Dec; 30(12):1949-61. PubMed ID: 18403053
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition-induced downregulation of Akt/GSK-3β pathway contributes to abnormality of tau in hippocampal slice.
Xie M; Shi R; Pan Y; Zeng T; Chen Q; Wang S; Liao X
Mol Neurobiol; 2014 Dec; 50(3):888-95. PubMed ID: 24752588
[TBL] [Abstract][Full Text] [Related]
8. Effects of tau phosphorylation on proteasome activity.
Ren QG; Liao XM; Chen XQ; Liu GP; Wang JZ
FEBS Lett; 2007 Apr; 581(7):1521-8. PubMed ID: 17376439
[TBL] [Abstract][Full Text] [Related]
9. Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation.
Butler D; Brown QB; Chin DJ; Batey L; Karim S; Mutneja MS; Karanian DA; Bahr BA
Rejuvenation Res; 2005; 8(4):227-37. PubMed ID: 16313222
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B plays a critical role in inducing Alzheimer's disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice.
Wu Z; Ni J; Liu Y; Teeling JL; Takayama F; Collcutt A; Ibbett P; Nakanishi H
Brain Behav Immun; 2017 Oct; 65():350-361. PubMed ID: 28610747
[TBL] [Abstract][Full Text] [Related]
11. Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases.
Bahr BA; Wisniewski ML; Butler D
Rejuvenation Res; 2012 Apr; 15(2):189-97. PubMed ID: 22533430
[TBL] [Abstract][Full Text] [Related]
12. Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases.
Viswanathan K; Hoover DJ; Hwang J; Wisniewski ML; Ikonne US; Bahr BA; Wright DL
ACS Med Chem Lett; 2012 Nov; 3(11):920-4. PubMed ID: 24900408
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of 14-3-3z promotes tau phosphorylation at Ser262 and accelerates proteosomal degradation of synaptophysin in rat primary hippocampal neurons.
Qureshi HY; Han D; MacDonald R; Paudel HK
PLoS One; 2013; 8(12):e84615. PubMed ID: 24367683
[TBL] [Abstract][Full Text] [Related]
14. The Critical Role of Proteolytic Relay through Cathepsins B and E in the Phenotypic Change of Microglia/Macrophage.
Ni J; Wu Z; Peterts C; Yamamoto K; Qing H; Nakanishi H
J Neurosci; 2015 Sep; 35(36):12488-501. PubMed ID: 26354916
[TBL] [Abstract][Full Text] [Related]
15. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.
Mueller-Steiner S; Zhou Y; Arai H; Roberson ED; Sun B; Chen J; Wang X; Yu G; Esposito L; Mucke L; Gan L
Neuron; 2006 Sep; 51(6):703-14. PubMed ID: 16982417
[TBL] [Abstract][Full Text] [Related]
16. Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid.
Marsh J; Bagol SH; Williams RSB; Dickson G; Alifragis P
Neurobiol Dis; 2017 Oct; 106():63-75. PubMed ID: 28647556
[TBL] [Abstract][Full Text] [Related]
17. Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicity.
Wang Y; Wu Q; Anand BG; Karthivashan G; Phukan G; Yang J; Thinakaran G; Westaway D; Kar S
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):686-706. PubMed ID: 32716575
[TBL] [Abstract][Full Text] [Related]
18. Selective suppression of cathepsin L results from elevations in lysosomal pH and is followed by proteolysis of tau protein.
Bednarski E; Lynch G
Neuroreport; 1998 Jun; 9(9):2089-94. PubMed ID: 9674599
[TBL] [Abstract][Full Text] [Related]
19. Effects of corticosterone and amyloid-beta on proteins essential for synaptic function: implications for depression and Alzheimer's disease.
Wuwongse S; Cheng SS; Wong GT; Hung CH; Zhang NQ; Ho YS; Law AC; Chang RC
Biochim Biophys Acta; 2013 Dec; 1832(12):2245-56. PubMed ID: 23928361
[TBL] [Abstract][Full Text] [Related]
20. ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.
Liraz O; Boehm-Cagan A; Michaelson DM
Mol Neurodegener; 2013 May; 8():16. PubMed ID: 23684315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
